Vinay Prasad: The most interesting thing you’ll read about PFS, EFS, DFS in oncology this year

Vinay Prasad, Professor of Epidemiology and Biostatistics at University of California, shared a post by Nature Reviews Clinical Oncology on Twitter, adding:

“This 8000 word paper by brilliant UCSF School of Medicine M3 Anushka Walia is going to be the most interesting thing you read about PFS, EFS, DFS in oncology this year.

Even if you think you know these endpoints well, I promise you will learn something new.”

Quoting Nature Reviews Clinical Oncology’s post:

“In a new Perspective, Walia, Tuia and Vinay Prasad discuss the adoption of composite end points in oncology, their pro and cons, and advocate for separate reporting of component events to enable a better understanding of cancer biology and trial results.”

For the article click here.
Source: Vinay Prasad/Twitter and Nature Reviews Clinical Oncology/Twitter